Ascendis wins U.S. approval for therapy for children with dwarfism

Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Ascendis wins U.S. approval for therapy for children with dwarfism February 27, 202611:04 PM UTCUpdated ago By Reuters Read Next Business Delta orders 34 more Airbus A321neo jets in fleet renewal push February 27, 2026 · 9:43 PM UTCAerospace & Defensecategory · · ago Companies Ascendis Pharma A/S Biomarin Pharmaceutical Inc BridgeBio Pharma Inc Feb 27 (Reuters) - The U.S. Food and Drug Adminis ...